[ Price : $8.95]
A Reuters article looks into drug GMP issues raised by FDA inspections over the past decade at Thermo Fisher's Greenville, NC drug...[ Price : $8.95]
FDA updates CDRHs Customer Collaboration Portal to track the progress of PMA applications and accept Small Business Determination...[ Price : $8.95]
FDA says that 22% of new molecular entities required postmarketing requirements or postmarketing commitments to address knowledge ...[ Price : $8.95]
Johnson & Johnson discontinues a Phase 2 study evaluating mosnodenvir for preventing dengue virus in adults aged 18-65 years.[ Price : $8.95]
FDA says the shortage of Lillys Mounjaro and Zepbound has been resolved but other similar products remain in short supply.[ Price : $8.95]
FDA lifts a partial clinical hold on Avidity Biosciences delpacibart etedesiran (del-desiran/AOC 1001) that is being evaluated for...[ Price : $8.95]
FDA has released the form FDA-483 with five observations from an inspection at the Lakewood, CO-based BSO outsourcing facility.[ Price : $8.95]
FDA releases a list of 18 drug products for which there was a potential signal of serious risks or new safety information in the s...